Health Canada approves Cosenty, a biologic therapy, for the treatment of adults with moderate to severe Hidradenitis ...
Approval is based on the two largest Phase III trials conducted in HS – SUNSHINE and SUNRISE – demonstrating the safety and efficacy of Cosentyx® in HS1 HS is a chronic, immunological, inflammatory skin condition estimated to affect 1 in 100 people …